Enthesitis in psoriatic arthritis

Seminars in Arthritis and Rheumatism

Volumn 43, Issue 3, 2013, Pages 325-334

  Sakkas, Lazaros I ^a,b   Alexiou, Ioannis ^a   Simopoulou, Theodora ^a   Vlychou, Marianna ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b OLD DOMINION UNIVERSITY   (United States)

Author keywords

Assessment; Dactylitis; Enthesitis; Magnetic resonance imaging; Psoriasis; Psoriatic arthritis; TNF inhibitors; Treatment; Ultrasonography

Indexed keywords

ADALIMUMAB; DEXAMETHASONE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; FLUORODEOXYGLUCOSE F 18; GOLIMUMAB; INFLIXIMAB; INTERLEUKIN 23; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; STEROID; TUMOR NECROSIS FACTOR INHIBITOR;

ARTICLE; BONE SCINTISCANNING; CLINICAL EXAMINATION; COMPOSITE PSORIATIC DISEASE ACTIVITY INDEX; DACTYLITIS; DISEASE ACTIVITY; DRUG DOSE COMPARISON; ECHOGRAPHY; ENTHESITIS; ENTHESOPATHY; FUNCTIONAL STATUS; HUMAN; HYPERALGESIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PSORIASIS; PSORIATIC ARTHRITIS; PSORIATIC ARTHRITIS DISEASE ACTIVITY SCORE; QUALITY OF LIFE; SCORING SYSTEM; SPONDYLARTHRITIS;

ASSESSMENT; DACTYLITIS; ENTHESITIS; MAGNETIC RESONANCE IMAGING; PSORIASIS; PSORIATIC ARTHRITIS; TNFΑ INHIBITORS; TREATMENT; ULTRASONOGRAPHY;

ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; DISEASE PROGRESSION; HUMANS; RHEUMATIC DISEASES;

EID: 84889579234     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2013.04.005     Document Type: Article

References (157)

1. Alenius G.M., Stenberg B., Stenlund H., Lundblad M., Dahlqvist S.R. Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire. J Rheumatol 2002, 29(12):2577-2582.
2. Reich K., Kruger K., Mossner R., Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 2009, 160(5):1040-1047.
3. Haroon M., Kirby B., Fitzgerald O. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Ann Rheum Dis 2013, 72(5):736-740.
4. Eder L., Chandran V., Shen H., Cook R.J., Shanmugarajah S., Rosen C.F., et al. Incidence of arthritis in a prospective cohort of psoriasis patients. Arthritis Care Res (Hoboken) 2011, 63(4):619-622.
5. Langley R.G., Krueger G.G., Griffiths C.E. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005, 64(Suppl. 2):ii18-ii23. [discussion ii4-5].
6. Moll J.M., Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973, 3(1):55-78.
7. Gladman D.D., Antoni C., Mease P., Clegg D.O., Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005, 64(Suppl. 2):ii14-ii17.
8. Michet C.J., Mason T.G., Mazlumzadeh M. Hip joint disease in psoriatic arthritis: risk factors and natural history. Ann Rheum Dis 2005, 64(7):1068-1070.
9. Gladman D.D., Chandran V. Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program. Rheumatology (Oxford) 2011, 50(1):25-31.
10. Dhir V., Aggarwal A. Psoriatic arthritis: a critical review. Clin Rev Allergy Immunol 2013, 44(2):141-148.
11. Salvarani C., Cantini F., Olivieri I., Macchioni P., Niccoli L., Padula A., et al. Isolated peripheral enthesitis and/or dactylitis: a subset of psoriatic arthritis. J Rheumatol 1997, 24(6):1106-1110.
12. Taylor W., Gladman D., Helliwell P., Marchesoni A., Mease P., Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006, 54(8):2665-2673.
13. Coates L.C., Conaghan P.G., Emery P., Green M.J., Ibrahim G., MacIver H., et al. Sensitivity and specificity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum 2012, 64(10):3150-3155.
14. Dougados M., van der Linden S., Juhlin R., Huitfeldt B., Amor B., Calin A., et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991, 34(10):1218-1227.
15. Rudwaleit M., van der Heijde D., Landewe R., Listing J., Akkoc N., Brandt J., et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009, 68(6):777-783.
16. Rudwaleit M., van der Heijde D., Landewe R., Akkoc N., Brandt J., Chou C.T., et al. The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011, 70(1):25-31.
17. Turan Y., Duruoz M.T., Cerrahoglu L. Relationship between enthesitis, clinical parameters and quality of life in spondyloarthritis. Joint Bone Spine 2009, 76(6):642-647.
18. McGonagle D., Gibbon W., Emery P. Classification of inflammatory arthritis by enthesitis. Lancet 1998, 352(9134):1137-1140.
19. Francois R.J., Braun J., Khan M.A. Entheses and enthesitis: a histopathologic review and relevance to spondyloarthritides. Curr Opin Rheumatol 2001, 13(4):255-264.
20. Benjamin M., McGonagle D. Histopathologic changes at "synovio-entheseal complexes" suggesting a novel mechanism for synovitis in osteoarthritis and spondylarthritis. Arthritis Rheum 2007, 56(11):3601-3609.
21. McGonagle D., Lories R.J., Tan A.L., Benjamin M. The concept of a "synovio-entheseal complex" and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis Rheum 2007, 56(8):2482-2491.
22. Sherlock J.P., Joyce-Shaikh B., Turner S.P., Chao C.C., Sathe M., Grein J., et al. IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4-CD8- entheseal resident T cells. Nat Med 2012, 18(7):1069-1076.
23. Mandl P., Niedermayer D.S., Balint P.V. Ultrasound for enthesitis: handle with care!. Ann Rheum Dis 2012, 71(4):477-479.
24. Fitzgerald O., Winchester R. Psoriatic arthritis: from pathogenesis to therapy. Arthritis Res Ther 2009, 11(1):214.
25. Queiro R., Gonzalez S., Alperi M., Alonso S., Lopez-Larrea C., Martinez-Borra J., et al. HLA-DR17 is associated with enthesitis in psoriatic arthritis. Joint Bone Spine 2011, 78(4):428-429.
26. McGonagle D. Enthesitis: an autoinflammatory lesion linking nail and joint involvement in psoriatic disease. J Eur Acad Dermatol Venereol 2009, 23(Suppl. 1):9-13.
27. McGonagle D., Tan A.L., Benjamin M. The biomechanical link between skin and joint disease in psoriasis and psoriatic arthritis: what every dermatologist needs to know. Ann Rheum Dis 2008, 67(1):1-4.
28. Lories R.J., Matthys P., de Vlam K., Derese I., Luyten F.P. Ankylosing enthesitis, dactylitis, and onychoperiostitis in male DBA/1 mice: a model of psoriatic arthritis. Ann Rheum Dis 2004, 63(5):595-598.
29. Lories R.J., Derese I., de Bari C., Luyten F.P. Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis. Arthritis Rheum 2007, 56(2):489-497.
30. Braem K., Deroose C.M., Luyten F.P., Lories R.J. Inhibition of inflammation but not ankylosis by glucocorticoids in mice: further evidence for the entheseal stress hypothesis. Arthritis Res Ther 2012, 14(2):R59.
31. Tan A.L., Benjamin M., Toumi H., Grainger A.J., Tanner S.F., Emery P., et al. The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis-a high-resolution MRI and histological study. Rheumatology (Oxford) 2007, 46(2):253-256.
32. Frediani B., Falsetti P., Storri L., Allegri A., Bisogno S., Baldi F., et al. Ultrasound and clinical evaluation of quadricipital tendon enthesitis in patients with psoriatic arthritis and rheumatoid arthritis. Clin Rheumatol 2002, 21(4):294-298.
33. Marchesoni A., Atzeni F., Spadaro A., Lubrano E., Provenzano G., Cauli A., et al. Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia. J Rheumatol 2012, 39(4):849-855.
34. Secundini R., Scheines E.J., Gusis S.E., Riopedre A.M., Citera G., Maldonado Cocco J.A. Clinico-radiological correlation of enthesitis in seronegative spondyloarthropathies (SNSA). Clin Rheumatol 1997, 16(2):129-132.
35. Eshed I., Bollow M., McGonagle D.G., Tan A.L., Althoff C.E., Asbach P., et al. MRI of enthesitis of the appendicular skeleton in spondyloarthritis. Ann Rheum Dis 2007, 66(12):1553-1559.
36. Jennings F., Lambert E., Fredericson M. Rheumatic diseases presenting as sports-related injuries. Sports Med 2008, 38(11):917-930.
37. Slobodin G., Rozenbaum M., Boulman N., Rosner I. Varied presentations of enthesopathy. Semin Arthritis Rheum 2007, 37(2):119-126.
38. Weckbach S., Schewe S., Michaely H.J., Steffinger D., Reiser M.F., Glaser C. Whole-body M.R. imaging in psoriatic arthritis: additional value for therapeutic decision making. Eur J Radiol 2011, 77(1):149-155.
39. Falsetti P., Frediani B., Filippou G., Acciai C., Baldi F., Storri L., et al. Enthesitis of proximal insertion of the deltoid in the course of seronegative spondyloarthritis. An atypical enthesitis that can mime impingement syndrome. Scand J Rheumatol 2002, 31(3):158-162.
40. Vincent V., Zabraniecki L., Loustau O., Godfrin B., Latour F.B., Railhac J.J., et al. Acitretin-induced enthesitis in a patient with psoriatic arthritis. Joint Bone Spine 2005, 72(4):326-329.
41. Descamps O.S., Leysen X., Van Leuven F., Heller F.R. The use of Achilles tendon ultrasonography for the diagnosis of familial hypercholesterolemia. Atherosclerosis 2001, 157(2):514-518.
42. Batista F., Nery C., Pinzur M., Monteiro A.C., de Souza E.F., Felippe F.H., et al. Achilles tendinopathy in diabetes mellitus. Foot Ankle Int 2008, 29(5):498-501.
43. Tan A.L., Grainger A.J., Tanner S.F., Emery P., McGonagle D. A high-resolution magnetic resonance imaging study of distal interphalangeal joint arthropathy in psoriatic arthritis and osteoarthritis: are they the same?. Arthritis Rheum 2006, 54(4):1328-1333.
44. Vlychou M., Koutroumpas A., Alexiou I., Fezoulidis I., Sakkas L.I. High-resolution ultrasonography and 3.0T magnetic resonance imaging in erosive and nodal hand osteoarthritis: high frequency of erosions in nodal osteoarthritis. Clin Rheumatol 2013, Jan 15. Epud ahead of print.
45. Brockbank J.E., Stein M., Schentag C.T., Gladman D.D. Dactylitis in psoriatic arthritis: a marker for disease severity?. Ann Rheum Dis 2005, 64(2):188-190.
46. Helliwell P.S., Porter G., Taylor W.J. Polyarticular psoriatic arthritis is more like oligoarticular psoriatic arthritis, than rheumatoid arthritis. Ann Rheum Dis 2007, 66(1):113-117.
47. Kane D., Stafford L., Bresnihan B., FitzGerald O. A classification study of clinical subsets in an inception cohort of early psoriatic peripheral arthritis-'DIP or not DIP revisited'. Rheumatology (Oxford) 2003, 42(12):1469-1476.
48. Rothschild B.M., Pingitore C., Eaton M. Dactylitis: implications for clinical practice. Semin Arthritis Rheum 1998, 28(1):41-47.
49. D'Agostino M.A., Olivieri I. Enthesitis. Best Pract Res Clin Rheumatol 2006, 20(3):473-486.
50. Heuft-Dorenbosch L., Spoorenberg A., van Tubergen A., Landewe R., van ver Tempel H., Mielants H., et al. Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 2003, 62(2):127-132.
51. Dandorfer S.W., Rech J., Manger B., Schett G., Englbrecht M. Differences in the patient's and the physician's perspective of disease in psoriatic arthritis. Semin Arthritis Rheum 2012, 42(1):32-41.
52. Mease P.J. Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI). Arthritis Care Res (Hoboken) 2011, 63(Suppl. 11):S64-S85.
53. Mander M., Simpson J.M., McLellan A., Walker D., Goodacre J.A., Dick W.C. Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis. Ann Rheum Dis 1987, 46(3):197-202.
54. Kavanaugh A., van der Heijde D., McInnes I.B., Mease P., Krueger G.G., Gladman D.D., et al. Golimumab in psoriatic arthritis: one-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial. Arthritis Rheum 2012, 64(8):2504-2517.
55. Maksymowych W.P., Mallon C., Morrow S., Shojania K., Olszynski W.P., Wong R.L., et al. Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index. Ann Rheum Dis 2009, 68(6):948-953.
56. Braun J., Brandt J., Listing J., Zink A., Alten R., Golder W., et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002, 359(9313):1187-1193.
57. Healy P.J., Helliwell P.S. Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum 2008, 59(5):686-691.
58. Gorman J.D., Sack K.E., Davis J.C. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med 2002, 346(18):1349-1356.
59. van der Heijde D., Braun J., Deodhar A., Inman R.D., Xu S., Mack M.E., et al. Comparison of three enthesitis indices in a multicentre, randomized, placebo-controlled trial of golimumab in ankylosing spondylitis (GO-RAISE). Rheumatology (Oxford) 2012, 52(2):321-325.
60. Coates L.C., Helliwell P.S. Disease measurement-enthesitis, skin, nails, spine and dactylitis. Best Pract Res Clin Rheumatol 2010, 24(5):659-670.
61. Yasser R., Yasser E., Hanan D., Nashwa el S., Rasker J.J. Enthesitis in seronegative spondyloarthropathies with special attention to the knee joint by MRI: a step forward toward understanding disease pathogenesis. Clin Rheumatol 2011, 30(3):313-322.
62. Gladman D.D., Cook R.J., Schentag C., Feletar M., Inman R.I., Hitchon C., et al. The clinical assessment of patients with psoriatic arthritis: results of a reliability study of the spondyloarthritis research consortium of Canada. J Rheumatol 2004, 31(6):1126-1131.
63. Gandjbakhch F., Terslev L., Joshua F., Wakefield R.J., Naredo E., D'Agostino M.A. Ultrasound in the evaluation of enthesitis: status and perspectives. Arthritis Res Ther 2011, 13(6):R188.
64. Taniguchi Y., Kumon Y., Takata T., Sano S., Ohnishi T., Nogami M., et al. Imaging assessment of enthesitis in spondyloarthritis. Ann Nucl Med 2012, 27(2):105-111.
65. Barozzi L., Olivieri I., De Matteis M., Padula A., Pavlica P. Seronegative spondylarthropathies: imaging of spondylitis, enthesitis and dactylitis. Eur J Radiol 1998, 27(Suppl. 1):S12-S17.
66. Anandarajah A. Imaging in psoriatic arthritis. Clin Rev Allergy Immunol 2012, 44(2):157-165.
67. De Filippis L.G., Caliri A., Lo Gullo R., Bartolone S., Miceli G., Cannavo S.P., et al. Ultrasonography in the early diagnosis of psoriasis-associated enthesopathy. Int J Tissue React 2005, 27(4):159-162.
68. Bandinelli F., Prignano F., Bonciani D., Bartoli F., Collaku L., Candelieri A., et al. Ultrasound detects occult entheseal involvement in early psoriatic arthritis independently of clinical features and psoriasis severity. Clin Exp Rheumatol 2013, 31(2):219-224.
69. Freeston J.E., Coates L.C., Helliwell P.S., Hensor E.M., Wakefield R.J., Emery P., et al. Is there subclinical enthesitis in early psoriatic arthritis? A clinical comparison with power Doppler ultrasound. Arthritis Care Res (Hoboken) 2012, 64(10):1617-1621.
70. Ostergaard M., Poggenborg R.P. Magnetic resonance imaging in psoriatic arthritis-update on current status and future perspectives: a report from the GRAPPA 2010 annual meeting. J Rheumatol 2012, 39(2):408-412.
71. Aydin S.Z., Bas E., Basci O., Filippucci E., Wakefield R.J., Celikel C., et al. Validation of ultrasound imaging for Achilles entheseal fibrocartilage in bovines and description of changes in humans with spondyloarthritis. Ann Rheum Dis 2010, 69(12):2165-2168.
72. Wiell C., Szkudlarek M., Hasselquist M., Moller J.M., Vestergaard A., Norregaard J., et al. Ultrasonography, magnetic resonance imaging, radiography, and clinical assessment of inflammatory and destructive changes in fingers and toes of patients with psoriatic arthritis. Arthritis Res Ther 2007, 9(6):R119.
73. Kane D. The role of ultrasound in the diagnosis and management of psoriatic arthritis. Curr Rheumatol Rep 2005, 7(4):319-324.
74. Solivetti F.M., Elia F., Teoli M., De Mutiis C., Chimenti S., Berardesca E., et al. Role of contrast-enhanced ultrasound in early diagnosis of psoriatic arthritis. Dermatology 2010, 220(1):25-31.
75. Balint P.V., Kane D., Wilson H., McInnes I.B., Sturrock R.D. Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis 2002, 61(10):905-910.
76. Kaeley G.S. Review of the use of ultrasound for the diagnosis and monitoring of enthesitis in psoriatic arthritis. Curr Rheumatol Rep 2011, 13(4):338-345.
77. Munoz-Fernandez S., de Miguel E., Cobo-Ibanez T., Madero R., Ferreira A., Hidalgo M.V., et al. Enthesis inflammation in recurrent acute anterior uveitis without spondylarthritis. Arthritis Rheum 2009, 60(7):1985-1990.
78. Gutierrez M., Filippucci E., Grassi W., Rosemffet M. Intratendinous power Doppler changes related to patient position in seronegative spondyloarthritis. J Rheumatol 2010, 37(5):1057-1059.
79. D'Agostino M.A. Role of ultrasound in the diagnostic work-up of spondyloarthritis. Curr Opin Rheumatol 2012, 24(4):375-379.
80. McGonagle D., Gibbon W., O'Connor P., Green M., Pease C., Emery P. Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy. Arthritis Rheum 1998, 41(4):694-700.
81. McGonagle D., Marzo-Ortega H., O'Connor P., Gibbon W., Pease C., Reece R., et al. The role of biomechanical factors and HLA-B27 in magnetic resonance imaging-determined bone changes in plantar fascia enthesopathy. Arthritis Rheum 2002, 46(2):489-493.
82. Jevtic V., Watt I., Rozman B., Kos-Golja M., Demsar F., Jarh O. Distinctive radiological features of small hand joints in rheumatoid arthritis and seronegative spondyloarthritis demonstrated by contrast-enhanced (Gd-DTPA) magnetic resonance imaging. Skeletal Radiol 1995, 24(5):351-355.
83. Godfrin B., Zabraniecki L., Lamboley V., Bertrand-Latour F., Sans N., Fournie B. Spondyloarthropathy with entheseal pain. A prospective study in 33 patients. Joint Bone Spine 2004, 71(6):557-562.
84. Rudwaleit M., Jurik A.G., Hermann K.G., Landewe R., van der Heijde D., Baraliakos X., et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis 2009, 68(10):1520-1527.
85. Spira D., Kotter I., Henes J., Kummerle-Deschner J., Schulze M., Boss A., et al. MRI findings in psoriatic arthritis of the hands. Am J Roentgenol 2011, 195(5):1187-1193.
86. Tan A.L., McGonagle D. Psoriatic arthritis: correlation between imaging and pathology. Joint Bone Spine 2010, 77(3):206-211.
87. Coates L.C., Hodgson R., Conaghan P.G., Freeston J.E. MRI and ultrasonography for diagnosis and monitoring of psoriatic arthritis. Best Pract Res Clin Rheumatol 2012, 26(6):805-822.
88. Sankowski A.J., Lebkowska U.M., Cwikla J., Walecka I., Walecki J. The comparison of efficacy of different imaging techniques (conventional radiography, ultrasonography, magnetic resonance) in assessment of wrist joints and metacarpophalangeal joints in patients with psoriatic arthritis. Pol J Radiol 2013, 78(1):18-29.
89. Keen H.I., Mease P.J., Bingham C.O., Giles J.T., Kaeley G., Conaghan P.G. Systematic review of MRI, ultrasound, and scintigraphy as outcome measures for structural pathology in interventional therapeutic studies of knee arthritis: focus on responsiveness. J Rheumatol 2011, 38(1):142-154.
90. D'Agostino M.A., Said-Nahal R., Hacquard-Bouder C., Brasseur J.L., Dougados M., Breban M. Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross-sectional study. Arthritis Rheum 2003, 48(2):523-533.
91. Chandran V., Gottlieb A., Cook R.J., Duffin K.C., Garg A., Helliwell P., et al. International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthritis Rheum 2009, 61(9):1235-1242.
92. Helliwell P.S., Firth J., Ibrahim G.H., Melsom R.D., Shah I., Turner D.E. Development of an assessment tool for dactylitis in patients with psoriatic arthritis. J Rheumatol 2005, 32(9):1745-1750.
93. Healy P.J., Helliwell P.S. Measuring dactylitis in clinical trials: which is the best instrument to use?. J Rheumatol 2007, 34(6):1302-1306.
94. Kaeley G.S., D'Agostino M.A., Grassi W., Ostergaard M., Olivieri I. GRAPPA 2011: proceedings from the ultrasound imaging module. J Rheumatol 2012, 39(11):2211-2213.
95. Namey T.C., Rosenthall L. Periarticular uptake of 99mtechnetium diphosphonate in psoriatics: correlation with cutaneous activity. Arthritis Rheum 1976, 19(3):607-612.
96. Erdem C.Z., Tekin N.S., Sarikaya S., Erdem L.O., Gulec S. MR imaging features of foot involvement in patients with psoriasis. Eur J Radiol 2008, 67(3):521-525.
97. Palazzi C., Lubrano E., D'Angelo S., Olivieri I. Beyond early diagnosis: occult psoriatic arthritis. J Rheumatol 2010, 37(8):1556-1558.
98. Naredo E., Moller I., de Miguel E., Batlle-Gualda E., Acebes C., Brito E., et al. High prevalence of ultrasonographic synovitis and enthesopathy in patients with psoriasis without psoriatic arthritis: a prospective case-control study. Rheumatology (Oxford) 2011, 50(10):1838-1848.
99. Gutierrez M., Filippucci E., De Angelis R., Salaffi F., Filosa G., Ruta S., et al. Subclinical entheseal involvement in patients with psoriasis: an ultrasound study. Semin Arthritis Rheum 2011, 40(5):407-412.
100. Ozcakar L., Cetin A., Inanici F., Kaymak B., Gurer C.K., Kolemen F. Ultrasonographical evaluation of the Achilles' tendon in psoriasis patients. Int J Dermatol 2005, 44(11):930-932.
101. Gisondi P., Tinazzi I., El-Dalati G., Gallo M., Biasi D., Barbara L.M., et al. Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case-control study. Ann Rheum Dis 2008, 67(1):26-30.
102. Ash Z.R., Tinazzi I., Gallego C.C., Kwok C., Wilson C., Goodfield M., et al. Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. Ann Rheum Dis 2012, 71(4):553-556.
103. Emad Y., Ragab Y., Gheita T., Anbar A., Kamal H., Saad A., et al. Knee enthesitis and synovitis on magnetic resonance imaging in patients with psoriasis without arthritic symptoms. J Rheumatol 2012, 39(10):1979-1986.
104. Offidani A., Cellini A., Valeri G., Giovagnoni A. Subclinical joint involvement in psoriasis: magnetic resonance imaging and X-ray findings. Acta Derm Venereol 1998, 78(6):463-465.
105. Tinazzi I., McGonagle D., Biasi D., Confente S., Caimmi C., Girolomoni G., et al. Preliminary evidence that subclinical enthesopathy may predict psoriatic arthritis in patients with psoriasis. J Rheumatol 2011, 38(12):2691-2692.
106. Girolomoni G., Gisondi P. Psoriasis and systemic inflammation: underdiagnosed enthesopathy. J Eur Acad Dermatol Venereol 2009, 23(Suppl. 1):3-8.
107. D'Agostino M.A., Aegerter P., Bechara K., Salliot C., Judet O., Chimenti M.S., et al. How to diagnose spondyloarthritis early? Accuracy of peripheral enthesitis detection by power Doppler ultrasonography. Ann Rheum Dis 2011, 70(8):1433-1440.
108. Gladman D.D., Thavaneswaran A., Chandran V., Cook R.J. Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease?. Ann Rheum Dis 2011, 70(12):2152-2154.
109. Helliwell P.S., Porter G. Sensitivity and specificity of plain radiographic features of peripheral enthesopathy at major sites in psoriatic arthritis. Skeletal Radiol 2007, 36(11):1061-1066.
110. Kane D., Stafford L., Bresnihan B., FitzGerald O. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford) 2003, 42(12):1460-1468.
111. Braun J., Rudwaleit M., Kary S., Kron M., Wong R.L., Kupper H. Clinical manifestations and responsiveness to adalimumab are similar in patients with ankylosing spondylitis with and without concomitant psoriasis. Rheumatology (Oxford) 2010, 49(8):1578-1589.
112. Love T.J., Gudbjornsson B., Gudjonsson J.E., Valdimarsson H. Psoriatic arthritis in Reykjavik, Iceland: prevalence, demographics, and disease course. J Rheumatol 2007, 34(10):2082-2088.
113. Rajendran C.P., Ledge S.G., Rani K.P., Madhavan R. Psoriatic arthritis. J Assoc Physicians India 2003, 51:1065-1068.
114. de Carvalho H.M., Bortoluzzo A.B., Goncalves C.R., da Silva J.A., Ximenes A.C., Bertolo M.B., et al. Gender characterization in a large series of Brazilian patients with spondyloarthritis. Clin Rheumatol 2012, 31(4):687-695.
115. Yang Q., Qu L., Tian H., Hu Y., Peng J., Yu X., et al. Prevalence and characteristics of psoriatic arthritis in Chinese patients with psoriasis. J Eur Acad Dermatol Venereol 2011, 25(12):1409-1414.
116. Rojas-Vargas M., Munoz-Gomariz E., Escudero A., Font P., Zarco P., Almodovar R., et al. First signs and symptoms of spondyloarthritis--data from an inception cohort with a disease course of two years or less (REGISPONSER-Early). Rheumatology (Oxford) 2009, 48(4):404-409.
117. Aydin S.Z., Ash Z.R., Tinazzi I., Castillo-Gallego C., Kwok C., Wilson C., et al. The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development. Ann Rheum Dis 2012, Aug 3. Epud ahead of print.
118. De Simone C., Guerriero C., Giampetruzzi A.R., Costantini M., Di Gregorio F., Amerio P. Achilles tendinitis in psoriasis: clinical and sonographic findings. J Am Acad Dermatol 2003, 49(2):217-222.
119. Delle Sedie A., Riente L., Filippucci E., Scire C.A., Iagnocco A., Gutierrez M., et al. Ultrasound imaging for the rheumatologist XXVI. Sonographic assessment of the knee in patients with psoriatic arthritis. Clin Exp Rheumatol 2010, 28(2):147-152.
120. Galluzzo E., Lischi D.M., Taglione E., Lombardini F., Pasero G., Perri G., et al. Sonographic analysis of the ankle in patients with psoriatic arthritis. Scand J Rheumatol 2000, 29(1):52-55.
121. Scarpa R., Cuocolo A., Peluso R., Atteno M., Gisonni P., Iervolino S., et al. Early psoriatic arthritis: the clinical spectrum. J Rheumatol 2008, 35(1):137-141.
122. Iagnocco A., Spadaro A., Marchesoni A., Cauli A., De Lucia O., Gabba A., et al. Power Doppler ultrasonographic evaluation of enthesitis in psoriatic arthritis. A multi-center study. Joint Bone Spine 2012, 79(3):324-325.
123. Fournie B., Margarit-Coll N., Champetier de Ribes T.L., Zabraniecki L., Jouan A., Vincent V., et al. Extrasynovial ultrasound abnormalities in the psoriatic finger. Prospective comparative power-Doppler study versus rheumatoid arthritis. Joint Bone Spine 2006, 73(5):527-531.
124. Gutierrez M., Filippucci E., Salaffi F., Di Geso L., Grassi W. Differential diagnosis between rheumatoid arthritis and psoriatic arthritis: the value of ultrasound findings at metacarpophalangeal joints level. Ann Rheum Dis 2011, 70(6):1111-1114.
125. Marzo-Ortega H., Tanner S.F., Rhodes L.A., Tan A.L., Conaghan P.G., Hensor E.M., et al. Magnetic resonance imaging in the assessment of metacarpophalangeal joint disease in early psoriatic and rheumatoid arthritis. Scand J Rheumatol 2009, 38(2):79-83.
126. Ibrahim G., Groves C., Chandramohan M., Beltran A., Valle R., Reyes B., et al. Clinical and ultrasound examination of the leeds enthesitis index in psoriatic arthritis and rheumatoid arthritis. ISRN Rheumatol 2011, 2011:731917.
127. Narvaez J., Narvaez J.A., de Albert M., Gomez-Vaquero C., Nolla J.M. Can magnetic resonance imaging of the hand and wrist differentiate between rheumatoid arthritis and psoriatic arthritis in the early stages of the disease?. Semin Arthritis Rheum 2012, 42(3):234-245.
128. Kane D., Greaney T., Bresnihan B., Gibney R., FitzGerald O. Ultrasonography in the diagnosis and management of psoriatic dactylitis. J Rheumatol 1999, 26(8):1746-1751.
129. Healy P.J., Groves C., Chandramohan M., Helliwell P.S. MRI changes in psoriatic dactylitis-extent of pathology, relationship to tenderness and correlation with clinical indices. Rheumatology (Oxford) 2008, 47(1):92-95.
130. Olivieri I., D'Angelo S., Scarano E., Padula A. What is the primary lesion in SpA dactylitis?. Rheumatology (Oxford) 2008, 47(5):561-562.
131. Olivieri I., Barozzi L., Pierro A., De Matteis M., Padula A., Pavlica P. Toe dactylitis in patients with spondyloarthropathy: assessment by magnetic resonance imaging. J Rheumatol 1997, 24(5):926-930.
132. Olivieri I., Salvarani C., Cantini F., Scarano E., Padula A., Niccoli L., et al. Fast spin echo-T2-weighted sequences with fat saturation in dactylitis of spondylarthritis. No evidence of entheseal involvement of the flexor digitorum tendons. Arthritis Rheum 2002, 46(11):2964-2967.
133. Radtke M.A., Reich K., Blome C., Rustenbach S., Augustin M. Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey. J Eur Acad Dermatol Venereol 2009, 23(6):683-691.
134. Antoni C.E., Kavanaugh A., Kirkham B., Tutuncu Z., Burmester G.R., Schneider U., et al. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT). Arthritis Rheum 2005, 52(4):1227-1236.
135. Payet J., Gossec L., Paternotte S., Burki V., Durnez A., Elhai M., et al. Prevalence and clinical characteristics of dactylitis in spondylarthritis: a descriptive analysis of 275 patients. Clin Exp Rheumatol 2012, 30(2):191-196.
136. Naredo E., Batlle-Gualda E., Garcia-Vivar M.L., Garcia-Aparicio A.M., Fernandez-Sueiro J.L., Fernandez-Prada M., et al. Power Doppler ultrasonography assessment of entheses in spondyloarthropathies: response to therapy of entheseal abnormalities. J Rheumatol 2010, 37(10):2110-2117.
137. Mumtaz A., Gallagher P., Kirby B., Waxman R., Coates L.C., Veale J.D., et al. Development of a preliminary composite disease activity index in psoriatic arthritis. Ann Rheum Dis 2011, 70(2):272-277.
138. FitzGerald O., Helliwell P., Mease P., Mumtaz A., Coates L., Pedersen R., et al. Application of composite disease activity scores in psoriatic arthritis to the PRESTA data set. Ann Rheum Dis 2012, 71(3):358-362.
139. Coates L.C., Fransen J., Helliwell P.S. Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis 2010, 69(1):48-53.
140. Baranauskaite A., Raffayova H., Kungurov N.V., Kubanova A., Venalis A., Helmle L., et al. Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study. Ann Rheum Dis 2012, 71(4):541-548.
141. Fraser A.D., van Kuijk A.W., Westhovens R., Karim Z., Wakefield R., Gerards A.H., et al. A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis. Ann Rheum Dis 2005, 64(6):859-864.
142. Clegg D.O., Reda D.J., Mejias E., Cannon G.W., Weisman M.H., Taylor T., et al. Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 1996, 39(12):2013-2020.
143. Kumar N., Kay L.J., Walker D.J. The treatment of enthesitis in psoriatic arthritis. J Rheumatol 2004, 31(11):2311-2312. [author reply 2-3].
144. Dougados M., vam der Linden S., Leirisalo-Repo M., Huitfeldt B., Juhlin R., Veys E., et al. Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum 1995, 38(5):618-627.
145. Kingsley G.H., Kowalczyk A., Taylor H., Ibrahim F., Packham J.C., McHugh N.J., et al. A randomized placebo-controlled trial of methotrexate in psoriatic arthritis. Rheumatology (Oxford) 2012, 51(8):1368-1377.
146. Behrens F., Finkenwirth C., Pavelka K., Stolfa J., Sipek-Dolnicar A., Thaci D., et al. Leflunomide in psoriatic arthritis: results from a large European prospective observational study. Arthritis Care Res (Hoboken) 2012, 65(3):464-470.
147. Eder L., Chandran V., Ueng J., Bhella S., Lee K.A., Rahman P., et al. Predictors of response to intra-articular steroid injection in psoriatic arthritis. Rheumatology (Oxford) 2010, 49(7):1367-1373.
148. Marchesoni A., Altomare G., Matucci-Cerinic M., Balato N., Olivieri I., Salvarani C., et al. An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic disease. J Eur Acad Dermatol Venereol 2010, 24(5):578-586.
149. Gossec L., Smolen J.S., Gaujoux-Viala C., Ash Z., Marzo-Ortega H., van der Heijde D., et al. European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis 2012, 71(1):4-12.
150. Ritchlin C.T., Kavanaugh A., Gladman D.D., Mease P.J., Helliwell P., Boehncke W.H., et al. Treatment recommendations for psoriatic arthritis. Ann Rheum Dis 2009, 68(9):1387-1394.
151. Kavanaugh A., McInnes I., Mease P., Krueger G.G., Gladman D., Gomez-Reino J., et al. Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: twenty-four-week efficacy and safety results of a randomized, placebo-controlled study. Arthritis Rheum 2009, 60(4):976-986.
152. Gladman D.D., Sampalis J.S., Illouz O., Guerette B. Responses to adalimumab in patients with active psoriatic arthritis who have not adequately responded to prior therapy: effectiveness and safety results from an open-label study. J Rheumatol 2010, 37(9):1898-1906.
153. Kavanaugh A., Mease P. Treatment of psoriatic arthritis with tumor necrosis factor inhibitors: longer-term outcomes including enthesitis and dactylitis with golimumab treatment in the Longterm Extension of a Randomized, Placebo-controlled Study (GO-REVEAL). J Rheumatol 2012, 89:90-93.
154. Antoni C., Krueger G.G., de Vlam K., Birbara C., Beutler A., Guzzo C., et al. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis 2005, 64(8):1150-1157.
155. Sterry W., Ortonne J.P., Kirkham B., Brocq O., Robertson D., Pedersen R.D., et al. Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial. Br Med J 2010, 340:c147.
156. Milia A.F., Ibba-Manneschi L., Manetti M., Benelli G., Generini S., Messerini L., et al. Evidence for the prevention of enthesitis in HLA-B27/hbeta(2)m transgenic rats treated with a monoclonal antibody against TNF-alpha. J Cell Mol Med 2011, 15(2):270-279.
157. Gottlieb A., Menter A., Mendelsohn A., Shen Y.K., Li S., Guzzo C., et al. Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial. Lancet 2009, 373(9664):633-640.